Weiler; Sven
Patent Applications and Registrations
Patent applications and USPTO patent grants for Weiler; Sven.The latest application filed is for "aminopyridine derivatives and their use as selective alk-2 inhibitors".
- Weiler; Sven - Lorrach DE
- Weiler; Sven - Basel N/A CH
| Patent | Date |
|---|---|
| Pyridinone derivatives and their use as selective ALK-2 inhibitors Grant 11,160,797 - Arista , et al. November 2, 2 | 2021-11-02 |
| Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20210155606 - ARISTA; Luca ; et al. | 2021-05-27 |
| Aminopyridine derivatives and their use as selective ALK-2 inhibitors Grant 10,947,218 - Arista , et al. March 16, 2 | 2021-03-16 |
| Pyridinone derivatives and their use as selective ALK-2 inhibitors App 20200360357 - Arista; Luca ; et al. | 2020-11-19 |
| Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20200299265 - ARISTA; Luca ; et al. | 2020-09-24 |
| Aminopyridine derivatives and their use as selective ALK-2 inhibitors Grant 10,710,980 - Arista , et al. | 2020-07-14 |
| Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors App 20190161474 - ARISTA; Luca ; et al. | 2019-05-30 |
| Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors Grant 8,841,291 - McQuire , et al. September 23, 2 | 2014-09-23 |
| Selective Hydroxamic Acid Based Mmp-12 And Mmp-13 Inhibitors App 20140031399 - MCQUIRE; Leslie Wighton ; et al. | 2014-01-30 |
| Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives Grant 8,569,317 - Altmann , et al. October 29, 2 | 2013-10-29 |
| Quinazoline derivatives which promote the release of parathyroid hormone Grant 8,476,286 - Beerli , et al. July 2, 2 | 2013-07-02 |
| Organic compounds Grant 8,367,662 - Shaw , et al. February 5, 2 | 2013-02-05 |
| Organic compounds Grant 8,143,253 - Lizos , et al. March 27, 2 | 2012-03-27 |
| Phenylalkyl-imidazole-bisphosphonate Compounds App 20110257131 - Cotesta; Simona ; et al. | 2011-10-20 |
| Benzimidazole derivatives Grant 8,030,497 - Gerspacher , et al. October 4, 2 | 2011-10-04 |
| C2-C5-Alkyl-Imidazole-Bisphosphonates App 20110224173 - Weiler; Sven ; et al. | 2011-09-15 |
| C.sub.2-C.sub.5-alkyl-imidazole-bisphosphonates Grant 7,977,323 - Weiler , et al. July 12, 2 | 2011-07-12 |
| Selective Hydroxamic Acid Based Mmp-12 And Mmp-13 Inhibitors App 20110112076 - McQuire; Leslie Wighton ; et al. | 2011-05-12 |
| Organic Compounds App 20100210641 - Shaw; Duncan ; et al. | 2010-08-19 |
| Organic Compounds App 20100204235 - Lizos; Dimitrios ; et al. | 2010-08-12 |
| Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives Grant 7,696,216 - Altmann , et al. April 13, 2 | 2010-04-13 |
| Polycyclic Compounds App 20100087491 - Albert; Rainer ; et al. | 2010-04-08 |
| Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives App 20100063075 - Altmann; Eva ; et al. | 2010-03-11 |
| Chromen-2-One Derivatives App 20090318546 - Baenteli; Rolf ; et al. | 2009-12-24 |
| Benzimidazole derivatives App 20090170921 - Gerspacher; Marc ; et al. | 2009-07-02 |
| C2-C5-Alkyl-Imidazole-Bisphosphonates App 20090143337 - Weiler; Sven ; et al. | 2009-06-04 |
| Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands App 20080306124 - Albert; Rainer ; et al. | 2008-12-11 |
| Treatment of Autoimmune Diseases App 20080200438 - Albert; Rainer ; et al. | 2008-08-21 |
| Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives App 20060079685 - Altmann; Eva ; et al. | 2006-04-13 |
| Quinazoline derivatives App 20040180912 - Beerli, Rene ; et al. | 2004-09-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 